Grade My Investments

Pfizer Inc. (PFE) Stock Grade

PFE · Healthcare

C+
Grade updated: July 18, 2026
Computed by the GradeMyInvestments scoring model from revenue growth, profitability, balance-sheet strength, and analyst targets.
Market Cap
$141.5B
P/E Ratio
18.2
Revenue Growth (YoY)
-1.7%
Net Margin
12.4%
Return on Equity
9.0%
Dividend Yield
6.9%

About Pfizer Inc.'s fundamentals

Pfizer is a large-cap pharmaceutical company with a market capitalization of $141.5 billion and a valuation multiple of 18.2x earnings. The company is currently experiencing a contraction in revenues, which declined 1.7% year-over-year, though it maintains a healthy net profit margin of 12.4%. With a return on equity of 9.0%, Pfizer generates modest returns on shareholder capital, while offering investors a notably high dividend yield of 6.9%.

Track PFE free — no credit card required. Live grade + monthly AI report →